| Filed On | Filing |
|---|---|
| 16 Nov 2026 | SCHEDULE 13G/A |
| 13 Nov 2026 | Form 4 |
| 13 Nov 2026 | 144 |
| 05 Nov 2026 | 10-Q |
| 05 Nov 2026 |
8-K: Results of Operations and Financial Condition
SAN CLEMENTE, Calif., November 5, 2026 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced financial results for the quarterly period ende... |
| 03 Sep 2026 |
Form 4: Sanzone Virginia Ruth, VP, General Counsel
Sold 4,856 shares ($819K) |
| 03 Sep 2026 | 144 |
| 01 Sep 2026 |
Form 4: Bonnell Brian Michael, Chief Financial Officer
Sold 6,381 shares ($1.12M) |
| 01 Sep 2026 | 144 |
| 31 Aug 2026 |
Form 4: Bonnell Brian Michael, Chief Financial Officer
Sold 9,307 shares ($1.61M) |
| 31 Aug 2026 | 144 |
| 14 Aug 2026 | SCHEDULE 13G/A |
| 13 Aug 2026 |
Form 4: Woolson Daniel, VP, GM-Infusion Capital
Sold 5,417 shares ($982K) |
| 13 Aug 2026 | 144 |
| 13 Aug 2026 | SCHEDULE 13G/A |
| 12 Aug 2026 |
Form 4: Sousa Ben, Chief Information Officer
Sold 2,250 shares ($401K) |
| 12 Aug 2026 | 144 |
| 11 Aug 2026 |
Form 4: Voigtlander Christian B., Chief Operating Officer
Sold 8,929 shares ($1.63M) |
| 11 Aug 2026 |
Form 4: Finney Elisha W, Director
Sold 378 shares ($69K) |
| 11 Aug 2026 | 144 |
Loading...